Latest News
Researchers have identified a simple blood test that may be able to diagnose neurodegeneration before symptoms arise; this could lead to earlier diagnosis of Alzheimer’s disease.
A new imaging study will be the first to use the GE180 ligand tracer to detect neuroinflammation in Parkinson’s and Alzheimer’s disease brains.
An experimental drug being developed for the treatment of stroke may also prevent Alzheimer’s by preventing the build-up of toxic proteins.
Journal Articles
In this research article from Biomarkers in Medicine, researchers determine if serum levels of tau and BDNF can be used as severity biomarkers in multiple sclerosis.
In this research article from Journal of Comparative Effectiveness Research, a new network meta-analysis compares lurasidone and brexpiprazole in acute schizophrenia.
In this research article from Pain Management, researchers investigate the effects of pregabalin, gabapentin and gastroretentive gabapentin on simulated driving performance.
Autoimmune
Could hyaluronic acid contribute to chronic white matter injury?
Can living in a sunnier climate in your youth reduce the risk of MS?
Cerebrovascular disease
ANA 2018: key highlights and news stories
CNS/PNS/SNS
3D printed scaffold promotes nerve cell growth for spinal cord injury
Advances in enteric neurobiology – the ‘brain’ in the gut in health and disease
SfN18: Advances in brain–computer interfaces may improve therapies and prosthetics
Cognitive/neurodegenerative disorders
Could a blood test detect Alzheimer’s before symptoms appear?
Could an experimental imaging tracer detect inflammation in neurodegenerative diseases?
Alzheimer’s disease may be prevented by experimental stroke drug
Demyelinating disease
Biomarker discovery and development in multiple sclerosis: where are we now?
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Gilenya® gains EMA approval for pediatric multiple sclerosis
Development and pediatrics
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Gilenya® gains EMA approval for pediatric multiple sclerosis
Artificial intelligence and home videos: a new diagnostic method for autism?
Epilepsy and seizure
Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases
Cannabidiol for epilepsy expected to be available within 6 weeks: industry news round-up
Genetics
SfN18: The potential of gene therapy in neurological disorders
Treasure trove of 102 genes associated with autism identified
Monogenic neurodevelopmental disorders may not be as simple as they seem
Headache
US FDA warns of stroke risk with multiple sclerosis drug: industry news round-up
Alzheimer’s drug development halted following toxic reaction: industry news round-up
Aimovig® receives EMA license for the prevention of migraine
Immune disorders and inflammation
Inflammatory disease and anxiety: could endocannabinoids be a mechanism of comorbidity?
FENS 2018: Immune system offers new way of treating Alzheimer’s disease
FENS 2018: Could anxiety and inflammation be treated with cannabis?
Infection
ANA 2018: key highlights and news stories
Further evidence links herpes virus to Alzheimer’s disease
Could Alzheimer’s disease be kick-started by periodontal bacteria?
Injury/trauma
‘Punch drunk syndrome’: an introduction to CTE, clinical relevance and pathology
3D printed scaffold promotes nerve cell growth for spinal cord injury
Movement disorders
Wireless ‘pacemaker for the brain’ could treat tremors and seizures in neurological diseases
RESTORE-1: first patient dosed with gene therapy in Parkinson’s trial
BrainStorm scraps initial access to NurOwn® for amyotrophic lateral sclerosis
Neuro-ophthalmology
Vision in Alzheimer's disease: a focus on the anterior afferent pathway
Glaucoma research gives a glimpse of a novel neuroprotection mechanism
Neurometabolic
Epigenetics, opioids and immune regulation: interviews from SfN17
Jeffrey Iliff: glymphatics, Alzheimer’s and future directions
SfN17: Neurodegeneration and the microbiome – new research highlights
Neuromuscular
New genetic suspects identified for ALS and FTD
Novel discovery in motor neuron disease may pave the way for future treatments
EAN 2017: Guillain-Barré syndrome risk associated with month of birth
Neuropsychiatry
Mental illnesses may be treated with common somatic drugs
Warnings that stopping Gilenya® could make multiple sclerosis worse: industry news round-up
Oncology/tumor
Immunotherapy may be an effective treatment for some gliomas
Sexual dimorphism in glioblastoma: an interview with Justin Lathia
Warnings that stopping Gilenya® could make multiple sclerosis worse: industry news round-up
Pain
New smartphone application could detect first signs of opioid overdose
The opioid epidemic: could a vaccine prevent addiction and overdose?
Sleep
SfN18: Disrupted sleep may exacerbate anxiety and brain disorders
